Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).
Condition:   Healthy Interventions:   Drug: Sphingomod;   Drug: Gilenya Sponsors:   Genuine Research Center, Egypt;   Hikma Pharmaceuticals LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2020 Category: Research Source Type: clinical trials

Fingolimod in Endovascular Treatment of Ischemic Stroke
Condition:   Stroke Inflammation Intervention:   Drug: Fingolimod Sponsor:   Ning Wang, MD., PhD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials